Team Approach To Polypharmacy Evaluation And Reduction For General Practice Patients With Dementia: The Australian TAPERdem Study.
Funder
National Health and Medical Research Council
Funding Amount
$586,840.00
Summary
Dementia frequently coexists with other chronic conditions, posing a challenge to optimise medication use. Suboptimal pharmacological management of comorbidities exacerbates the rate of functional decline of PWD. The present study will determine to what extent improved medication management produces better health and functional outcomes for PWD.
Optimising The Management Of Comorbidities In Dementia: Reducing Disparaties And Improving Clinical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$603,894.00
Summary
Many individuals with dementia also have other chronic medical conditions. This research will help us better understand the comorbidities experienced by people with dementia and the impact these have on clinical outcomes This can lead to the development of consumer-centred management strategies. By ensuring the appropriate, equitable and timely treatment of comorbidities in people with dementia, there is potential to optimise the quality of life and health of people with dementia.
Methamphetamine Clandestine Laboratories: An Analysis Of The Geo-spatial Dynamics Between Ecological Factors, Pharmacists, Pseudo-runners And Related Health Harms.
Funder
National Health and Medical Research Council
Funding Amount
$320,891.00
Summary
Methamphetamine (MA) manufacture in clandestine laboratories (clan labs) presents serious health and environmental risks beyond the impact on MA users. My fellowship seeks to better understand the interplay between the geography and population features of clan lab locations, the role of pharmacists and pseudo-runners in MA manufacture and MA-related harm. This evidence provides critical information for policy and program development aimed at reducing the MA manufacture and MA-related harm.
Task-sharing For Cardiovascular Disease Management - Improving Access To Healthcare
Funder
National Health and Medical Research Council
Funding Amount
$419,179.00
Summary
The primary focus of this research program is to develop high quality research, designed to evaluate and provide evidence for the management of cardiovascular disease using ïtask-sharingÍ as a model of care. The specific objective is: To evaluate the effectiveness and cost-effectiveness of innovative task-sharing models of care through conducting cluster randomised trials in high and middle income countries.
An Integrated General Practice And Pharmacy-based Intervention To Promote The Prescription And Use Of Appropriate Preventive Medications Among Individuals At High Cardiovascular Risk.
Funder
National Health and Medical Research Council
Funding Amount
$2,380,071.00
Summary
We will conduct a randomised controlled trial that combines three methods to reduce risk factors and improve outcomes for people with cardiovascular disease (CVD). The methods include administration of a polypill, a GP-focused point-of-care intervention, and a pharmacy-led intervention to improve commencement and persistence with taking medications. We expect that integrating these three approaches will lead to large reductions in CVD risk factor levels for participants.
Vancomycin is the antibiotic we rely on for the treatment of major infections due to bacteria that are resistant to other antibiotics (MRSA). Vancomycin is monitored in each patient to individualise the dose. This is done to improve treatment efficacy, reduce adverse effects and to prevent antibiotic resistance. This project will introduce a vancomycin guideline and train hospital staff to use vancomycin safely, effectively and to minimise the development of resistance.
Antimicrobial Stewardship – Establishing An Effective Model For Australian Private Hospitals
Funder
National Health and Medical Research Council
Funding Amount
$55,807.00
Summary
Inappropriate and overuse of antibiotics in hospitals has accelerated world-wide antimicrobial resistance. Strategies to improve antibiotic prescribing have been effective in slowing down antibiotic resistance, however there has been little uptake of these strategies in Australian private hospitals. Needs, resources, and current barriers for these strategies will be investigated in the private hospital setting and results will be used to construct a program model that can be adopted by private h ....Inappropriate and overuse of antibiotics in hospitals has accelerated world-wide antimicrobial resistance. Strategies to improve antibiotic prescribing have been effective in slowing down antibiotic resistance, however there has been little uptake of these strategies in Australian private hospitals. Needs, resources, and current barriers for these strategies will be investigated in the private hospital setting and results will be used to construct a program model that can be adopted by private hospitals in AustraliaRead moreRead less
Communicating with older people across transition points of care. This project aims to examine how health professionals, older people and their family members communicate in managing medications as older people move through transition points of care. Communication problems often occur as older people move between and within settings, often leading to harmful medication incidents. The project expects to facilitate medication safety as older people move across different settings and to facilitate ....Communicating with older people across transition points of care. This project aims to examine how health professionals, older people and their family members communicate in managing medications as older people move through transition points of care. Communication problems often occur as older people move between and within settings, often leading to harmful medication incidents. The project expects to facilitate medication safety as older people move across different settings and to facilitate cultural shifts in health care communication and opportunities for consumer involvement.Read moreRead less
Physico-chemical and Biopharmaceutical Investigations of Novel Drug Delivery Systems for Oral Administration of Lipophilic Drugs. The new platform technology for carrying lipophilic molecules will be applicable to many molecules currently under development by Australian Industry and will inspire novel encapsulation approaches to new and existing drugs as well as functional foods and nutraceuticals. Improved oral bioavailability of anticancer drugs will improve the quality of life of patients, re ....Physico-chemical and Biopharmaceutical Investigations of Novel Drug Delivery Systems for Oral Administration of Lipophilic Drugs. The new platform technology for carrying lipophilic molecules will be applicable to many molecules currently under development by Australian Industry and will inspire novel encapsulation approaches to new and existing drugs as well as functional foods and nutraceuticals. Improved oral bioavailability of anticancer drugs will improve the quality of life of patients, reduce health care costs and provide broader benefits to the community. The Australian biotechnology/pharmaceutical industries can share in a greater proportion of the US$50 billion market for specialised drug delivery, which is increasing by 20% annually. Australia's scientific competitiveness will be strengthened in the fields of nano-encapsulation and colloidal delivery.Read moreRead less